Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 26.05.2026 GINC LN IE00BD842Y21 899,606.00 USD 57,963,650.20 64.432  ...

SAN DIEGO--(BUSINESS WIRE)--ClearNote Health announced the close of $52 million in Series D financing and appointment of Kevin Keegan as president and chief operating officer....

SAN FRANCISCO--(BUSINESS WIRE)--Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting...

LONDON & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and home to the largest and most liquid markets to trade energy derivatives, today announced record liquidity across its global natural gas and power markets, including record open interest (OI) across North American natural gas, as ICE reached record total OI across its futures and options mark...

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced that it will present new data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29-June 2 in Chicago. The findings in the poster presentation demonstrate the value of Arima’s Hi-C sequencing-based approach to fusion and rearrangement detection, available clinically through t...

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI therapeutic research and technology company, today announced the launch of its Pandemic Response Platform, a deployment configuration of the Company's proprietary HYFT® biological pattern system and LensAI™ platform purpose-built for outbreak preparedness, rapid countermeasure design, and pan-strain antigen and antibody generation against RNA viruses. The Platform draws on the same biological intelligence in...

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55 p.m. ET. A live webcast can be accessed in the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be avail...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Box (NYSE: BOX), the leading Intelligent Content Management (ICM) platform, today announced that members of its management team will present at the following conferences: BofA Securities 2026 Global Technology Conference Date and Time: June 3, 2026 at 8:40 am P.T. Location: San Francisco, CA 2026 Davidson Technology and Consumer Conference Date and Time: June 11, 2026 at 8:00 am C.T. Location: Nashville, TN These events will be webcast live at boxinvestorr...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced an alliance with bit.bio to create a comprehensive map of transcription factor-driven cell identity, encompassing both cell state and cell fate. This map will serve as the foundational blueprint for developing highly accurate, human-relevant models at scale. By precisely mimicking in vivo biological responses, these models will significantly advance pred...

CHICAGO--(BUSINESS WIRE)--Cardiosense, a healthcare technology company focused on heart failure care, today announced that the U.S. Food & Drug Administration (FDA) has granted De Novo classification for its PCWP Analysis Software™, a first-in-class technology to estimate a key indicator of heart health noninvasively. With this authorization, Cardiosense has a clear path forward in supporting clinicians who manage heart failure by providing critical data to improve therapy and avoid prolong...